1. Home
  2. SAIC vs LNTH Comparison

SAIC vs LNTH Comparison

Compare SAIC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

HOLD

Current Price

$96.50

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$77.51

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIC
LNTH
Founded
1969
1956
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.9B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
SAIC
LNTH
Price
$96.50
$77.51
Analyst Decision
Hold
Buy
Analyst Count
8
6
Target Price
$114.00
$83.20
AVG Volume (30 Days)
623.3K
1.0M
Earning Date
03-16-2026
05-06-2026
Dividend Yield
1.53%
N/A
EPS Growth
7.39
N/A
EPS
7.70
3.41
Revenue
$7,262,000,000.00
$343,374,000.00
Revenue This Year
$3.11
N/A
Revenue Next Year
$1.75
$13.47
P/E Ratio
$12.52
$23.56
Revenue Growth
N/A
3.62
52 Week Low
$81.08
$47.27
52 Week High
$124.11
$108.86

Technical Indicators

Market Signals
Indicator
SAIC
LNTH
Relative Strength Index (RSI) 56.82 53.93
Support Level $96.15 $77.38
Resistance Level $103.34 $83.70
Average True Range (ATR) 2.89 3.41
MACD 0.88 -0.30
Stochastic Oscillator 82.09 44.29

Price Performance

Historical Comparison
SAIC
LNTH

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: